The Epidemiology of Psoriatic Arthritis

Rheumatic Disease Clinics of North America

Volumn 41, Issue 4, 2015, Pages 545-568

  Ogdie, Alexis ^a   Weiss, Pamela ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Classification criteria; Comorbidity; Epidemiology; Juvenile psoriatic arthritis; Psoriatic arthritis; Risk factors; Screening tools

Indexed keywords

BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

AXIAL SPONDYLOARTHROPATHY; CHILDHOOD DISEASE; COMORBIDITY; DACTYLITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; ENTHESITIS; HUMAN; INCIDENCE; NAIL DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REFERENCE VALUE; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY; SYSTEMATIC REVIEW; ARTHRITIS, PSORIATIC; HEALTH; MORBIDITY; PROCEDURES; TRENDS;

ARTHRITIS, PSORIATIC; GLOBAL HEALTH; HUMANS; MORBIDITY; RISK ASSESSMENT; RISK FACTORS;

EID: 84945438141     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2015.07.001     Document Type: Review

References (195)

1. Ogdie A., Yu Y., Haynes K., et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 2015, 74(2):326-332.
2. Finzel S., Englbrecht M., Engelke K., et al. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 2011, 70(1):122-127.
3. Eder L., Gladman D.D. Psoriatic arthritis: phenotypic variance and nosology. Curr Rheumatol Rep 2013, 15:316.
4. Gelfand J.M., Gladman D.D., Mease P.J., et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005, 53(4):573.
5. Shbeeb M., Uramoto K.M., Gibson L.E., et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000, 27(5):1247-1250.
6. Asgari M.M., Wu J.J., Gelfand J.M., et al. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. Pharmacoepidemiol Drug Saf 2013, 22(8):842-849.
7. Cakir N., Pamuk Ö., Derviş E., et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 2012, 32(4):895-908.
8. Hanova P., Pavelka K., Holcatova I., et al. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol 2010, 39(4):310-317.
9. Löfvendahl S., Theander E., Svensson Å., et al. Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden-a population-based register study. PLoS One 2014, 9(5):e98024.
10. Love T., Gudbjornsson B., Gudjonsson J., et al. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol 2007, 34(10):2082-2088.
11. Ogdie A., Langan S., Love T., et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 2013, 52(3):568-575.
12. Pedersen O., Svendsen A., Ejstrup L., et al. The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis 2008, 67(10):1422-1426.
13. Soriano E., Rosa J., Velozo E., et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 2011, 50(4):729-734.
14. Li R., Sun J., Ren L.M., et al. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology 2012, 51(4):721-729.
15. Yang Q., Qu L., Tian H., et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2011, 25(12):1409-1414.
16. Nossent J., Gran J. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol 2009, 38(4):251-255.
17. Wilson F., Icen M., Crowson C., et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009, 61(2):233-239.
18. Alamanos Y., Voulgari P., Drosos A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008, 35(7):1354-1358.
19. Carneiro J.N., Paula A.P., Martins G.A. Psoriatic arthritis in patients with psoriasis: evaluation of clinical and epidemiological features in 133 patients followed at the University Hospital of Brasilia. An Bras Dermatol 2012, 87(4):539-544.
20. Henes J.C., Ziupa E., Eisfelder M., et al. High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study. Rheumatol Int 2014, 34(2):227-234.
21. Ibrahim G., Waxman R., Helliwell P. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009, 61(10):1373-1378.
22. Jamshidi F., Bouzari N., Seirafi H., et al. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch Iran Med 2008, 11(2):162-165.
23. Haroon M., Kirby B., FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013, 72(5):736-740.
24. Love T., Gudjonsson J., Valdimarsson H., et al. Psoriatic arthritis and onycholysis-results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol 2012, 39(7):1441-1444.
25. Mease P., Gladman D., Papp K., et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013, 69(5):729-735.
26. Khraishi M., Chouela E., Bejar M., et al. High prevalence of psoriatic arthritis in a cohort of patients with psoriasis seen in a dermatology practice. J Cutan Med Surg 2012, 16(2):122-127.
27. Radtke M., Reich K., Blome C., et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009, 23(6):683-691.
28. Reich K., Krüger K., Mössner R., et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009, 160(5):1040-1047.
29. Eder L., Chandran V., Shen H., et al. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken) 2011, 63(4):619-622.
30. Merola J., Wu S., Han J., et al. Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis 2014, 74:1495-1500.
31. Mody E., Husni M.E., Schur P., et al. Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience. Br J Dermatol 2007, 157(5):1050-1051.
32. Marchesoni A., Atzeni F., Spadaro A., et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012, 39(4):849-855.
33. De Marco G., Cattaneo A., Battafarano N., et al. Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. Arch Dermatol Res 2012, 304(9):719-726.
34. Tan A., Grainger A., Tanner S., et al. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same?. Arthritis Rheum 2006, 54(4):1328-1333.
35. Aggarwal R., Ringold S., Khanna D., et al. Distinctions between diagnostic and classification criteria?. Arthritis Care Res (Hoboken) 2015, 10.1002/acr.22583.
36. Moll J.M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973, 3(1):55-78.
37. Amor B., Dougados M., Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 1990, 57(2):85-89.
38. Dougados M., van der Linden S., Juhlin R., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34(10):1218-1227.
39. Bennett R.M. Psoriatic arthritis. Arthritis and allied conditions 1979, 645. Lea & Feb, Philadelphia. 9th edition. D.J. McCarty (Ed.).
40. Fournie B., Crognier L., Arnaud C., et al. Proposed classification criteria of psoriatic arthritis: a preliminary study in 260 patients. Rev Rhum Engl Ed 1999, 66(10):446-456.
41. Vasey F., Espinoza L.R. Psoriatic arthropathy. Spondyloarthropathies 1984, 151-185. Grune & Stratton, Orlando (FL). A. Calin (Ed.).
42. Taylor W., Helliwell P. Classification criteria for psoriatic arthritis: development of new criteria from a large international study [PsA - CASPAR]. Arthritis Rheum 2006, 54:2665-2673.
43. Congi L., Roussou E. Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria. Clin Exp Rheumatol 2010, 28(3):304-310.
44. Gunal E.K., Kamali S., Gul A., et al. Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis. Rheumatol Int 2008, 28(10):959-964.
45. D'Angelo S., Mennillo G., Cutro M., et al. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol 2009, 36(2):368-370.
46. van den Berg R., van Gaalen F., van der Helm-van Mil A., et al. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis cohort. Ann Rheum Dis 2012, 71(8):1366-1369.
47. Chandran V., Schentag C., Gladman D. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol 2008, 35(10):2069-2070.
48. Chandran V., Schentag C., Gladman D. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2007, 57(8):1560-1563.
49. Coates L., Conaghan P., Emery P., et al. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2012, 64(10):3150-3155.
50. Lueng Y.Y., Tam L.S., Ho K.W., et al. Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population. Rheumatology 2010, 49(1):112-115.
51. Rudwaleit M., van der Heijde D., Landewé R., et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70(1):25-31.
52. Rudwaleit M., van der Heijde D., Landewé R., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68(6):777-783.
53. Taylor W.J., Robinson P.C. Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis. Curr Rheumatol Rep 2013, 15(4):317.
54. Haddad A., Chandran V. Arthritis mutilans. Curr Rheumatol Rep 2013, 15(4):321.
55. Gladman D.D., Shuckett R., Russell M.L., et al. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q J Med 1987, 62(238):127-141.
56. Madland T., Apalset E., Johannessen A., et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005, 32(10):1918-1922.
57. Lindqvist U., Alenius G., Husmark T., et al. The Swedish early psoriatic arthritis register-2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008, 35(4):668-673.
58. Soy M., Karaca N., Umit E., et al. Joint and nail involvement in Turkish patients with psoriatic arthritis. Rheumatol Int 2008, 29(2):223-225.
59. Queiro R., Tejón P., Coto P., et al. Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis. Clin Dev Immunol 2013, 2013:482691.
60. Zisman D., Eder L., Elias M., et al. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int 2012, 32(3):595-600.
61. Queiro R., Alperi M., Alonso-Castro S., et al. Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset. Clin Exp Rheumatol 2012, 30(4):476-480.
62. Tillett W., McHugh N. Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotypes?. Curr Rheumatol Rep 2012, 14(4):334-342.
63. Queiro-Silva R., Torre-Alonso J.C., Tinture-Equren T., et al. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003, 62(1):68-70.
64. Gladman D., Ziouzina O., Thavaneswaran A., et al. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. J Rheumatol 2013, 40(8):1357-1359.
65. Chandran V., Tolusso D., Cook R., et al. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol 2010, 37(4):809-815.
66. Queiro R., Alperi M., Lopez A., et al. Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis. Joint Bone Spine 2008, 75(5):544-547.
67. Thavaneswaran A., Chandran V., Gladman D. Do patients with psoriatic arthritis fall into distinct clinical subgroups-a cluster analysis?. Arthritis Rheum 2012, 64(Suppl):S1106.
68. Ritchlin C., Kavanaugh A., Gladman D.D., et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009, 68:1387-1394.
69. McGonagle D., Helliwell P., Veale D. Enthesitis in psoriatic disease. Dermatology 2012, 225(2):100-109.
70. Sakkas L., Alexiou I., Simopoulou T., et al. Enthesitis in psoriatic arthritis. Semin Arthritis Rheum 2013, 43(3):325-334.
71. Weiss P.F., Chauvin N.A., Klink A.J., et al. Detection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonography. Arthritis Rheumatol 2014, 66(1):218-227.
72. D'Agostino M.A., Said-Nahal R., Hacquard-Bouder C., et al. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 2003, 48(2):523-533.
73. Weiss P., Beukelman T., Schanberg L., et al. Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry. J Rheumatol 2012, 39(12):2341-2351.
74. Healy P., Helliwell P. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008, 59(5):686-691.
75. Kaeley G. Review of the use of ultrasound for the diagnosis and monitoring of enthesitis in psoriatic arthritis. Curr Rheumatol Rep 2011, 13(4):338-345.
76. Coates L., Hodgson R., Conaghan P., et al. MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis. Best Pract Res Clin Rheumatol 2012, 26(6):805-822.
77. Payet J., Gossec L., Paternotte S., et al. Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients. Clin Exp Rheumatol 2012, 30(2):191-196.
78. Healy P., Groves C., Chandramohan M., et al. MRI changes in psoriatic dactylitis-extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford) 2008, 47(1):92-95.
79. Tuttle K.S., Vargas S.O., Callahan M.J., et al. Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity. Pediatr Rheumatol Online J 2015, 13:7.
80. Kyriakou A., Patsatsi A., Sotiriadis D. Detailed analysis of specific nail psoriasis features and their correlations with clinical parameters: a cross-sectional study. Dermatology 2011, 223(3):222-229.
81. Palmou N., Marzo-Ortega H., Ash Z., et al. Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritis. Dermatology 2011, 223(4):370-373.
82. Love T., Gudjonsson J., Valdimarsson H., et al. Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study. Scand J Rheumatol 2010, 39(4):299-302.
83. Baran R. The burden of nail psoriasis: an introduction. Dermatology 2010, 221(Suppl 1):1-5.
84. Jiaravuthisan M., Sasseville D., Vender R., et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007, 57(1):1-27.
85. Ash Z., Tinazzi I., Gallego C., et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis 2012, 71(4):553-556.
86. Augustin M., Reich K., Blome C., et al. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 2010, 163(3):580-585.
87. Prasad P.V., Bikku B., Kaviarasan P.K., et al. A clinical study of psoriatic arthropathy. Indian J Dermatol Venereol Leprol 2007, 73(3):166-170.
88. McGonagle D., Palmou Fontana N., Tan A., et al. Nailing down the genetic and immunological basis for psoriatic disease. Dermatology 2010, 221(Suppl 1):15-22.
89. Scarpa R., Cuocolo A., Peluso R., et al. Early psoriatic arthritis: the clinical spectrum. J Rheumatol 2008, 35(1):137-141.
90. Dalbeth N., Pui K., Lobo M., et al. Nail disease in psoriatic arthritis: distal phalangeal bone edema detected by magnetic resonance imaging predicts development of onycholysis and hyperkeratosis. J Rheumatol 2012, 39(4):841-843.
91. Aydin S., Castillo-Gallego C., Ash Z., et al. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology 2012, 225(3):231-235.
92. Kane D., Stafford L., Bresnihan B., et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003, 42(12):1460-1468.
93. Ichikawa N., Taniguchi A., Kobayashi S., et al. Performance of hands and feet radiographs in differentiation of psoriatic arthritis from rheumatoid arthritis. Int J Rheum Dis 2012, 15(5):462-467.
94. Narváez J., Narváez J.A., de Albert M., et al. Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease?. Semin Arthritis Rheum 2012, 42(3):234-245.
95. Tehranzadeh J., Ashikyan O., Anavim A., et al. Detailed analysis of contrast-enhanced MRI of hands and wrists in patients with psoriatic arthritis. Skeletal Radiol 2008, 37(5):433-442.
96. Fournié B., Margarit-Coll N., Champetier de Ribes T.L., et al. Extrasynovial ultrasound abnormalities in the psoriatic finger. Joint Bone Spine 2006, 73(5):527-531.
97. Aydin S., Ash Z., Tinazzi I., et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis 2013, 72(6):992-995.
98. Freeston J., Coates L., Nam J., et al. Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound. Arthritis Care Res (Hoboken) 2014, 66(3):432-439.
99. Weckbach S., Schewe S., Michaely H.J., et al. Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making. Eur J Radiol 2011, 77(1):149-155.
100. Augustin M., Glaeske G., Radtke M., et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010, 162(3):633-636.
101. Stoll M., Zurakowski D., Nigrovic L., et al. Patients with juvenile psoriatic arthritis comprise two distinct populations. Arthritis Rheum 2006, 54(11):3564-3572.
102. Berard R., Tomlinson G., Li X., et al. Description of active joint count trajectories in juvenile idiopathic arthritis. J Rheumatol 2014, 41(12):2466-2473.
103. Guzman J., Oen K., Tucker L., et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum Dis 2014, 10.1136/annrheumdis-2014-205372.
104. Nigrovic P. Juvenile psoriatic arthritis: bathwater or baby?. J Rheumatol 2009, 36(9):1861-1863.
105. Stoll M., Lio P., Sundel R., et al. Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Rheum 2008, 59(1):51-58.
106. Petty R., Southwood T., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31(2):390-392.
107. Demirkaya E., Ozen S., Bilginer Y., et al. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 2011, 29(1):111-116.
108. Flatø B., Lien G., Smerdel-Ramoya A., et al. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol 2009, 36(3):642-650.
109. Stoll M., Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol 2011, 23(5):437-443.
110. Häfner R., Michels H. Psoriatic arthritis in children. Curr Opin Rheumatol 1996, 8(5):467-472.
111. Stoll M., Nigrovic P. Subpopulations within juvenile psoriatic arthritis: a review of the literature. Clin Dev Immunol 2006, 13(2-4):377-380.
112. Calandra S., Gallo M., Consolaro A., et al. Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. J Rheumatol 2014, 41(7):1416-1425.
113. Gladman D. Early psoriatic arthritis. Rheum Dis Clin North Am 2012, 38(2):373-386.
114. Gladman D., Thavaneswaran A., Chandran V., et al. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?. Ann Rheum Dis 2011, 70(12):2152-2154.
115. Tillett W., Jadon D., Shaddick G., et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis 2013, 72(8):1358-1361.
116. Haroon M., Gallagher P., Fitzgerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2015, 74:1045-1050.
117. Kirkham B., de Vlam K., Li W., et al. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol 2015, 33(1):11-19.
118. Theander E., Husmark T., Alenius G., et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register(SwePsA). Ann Rheum Dis 2014, 73(2):407-413.
119. Sørensen J., Hetland M., All Departments of Rheumatology in Denmark Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Ann Rheum Dis 2015, 74(3):e12.
120. Palazzi C., Lubrano E., D'Angelo S., et al. Beyond early diagnosis: occult psoriatic arthritis. J Rheumatol 2010, 37(8):1556-1558.
121. McGonagle D., Ash Z., Dickie L., et al. The early phase of psoriatic arthritis. Ann Rheum Dis 2011, 70(Suppl 1):i71-i76.
122. Naredo E., Möller I., de Miguel E., et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford) 2011, 50(10):1838-1848.
123. Emad Y., Ragab Y., Bassyouni I., et al. Enthesitis and related changes in the knees in seronegative spondyloarthropathies and skin psoriasis: magnetic resonance imaging case-control study. J Rheumatol 2010, 37(8):1709-1717.
124. Erdem C., Tekin N., Sarikaya S., et al. MR imaging features of foot involvement in patients with psoriasis. Eur J Radiol 2008, 67(3):521-525.
125. Gisondi P., Tinazzi I., El-Dalati G., et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 2008, 67(1):26-30.
126. Raza N., Hameed A., Ali M. Detection of subclinical joint involvement in psoriasis with bone scintigraphy and its response to oral methotrexate. Clin Exp Dermatol 2008, 33(1):70-73.
127. Offidani A., Cellini A., Valeri G., et al. Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Derm Venereol 1998, 78(6):463-465.
128. Tinazzi I., McGonagle D., Domenico B., et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis [subclinical PsA]. J Rheumatol 2011, 38:2691-2692.
129. Ogdie A., Gelfand J. Identification of risk factors for psoriatic arthritis [risk factors]. Arch Dermatol 2010, 146(7):785.
130. Hsieh J., Kadavath S., Efthimiou P. Can traumatic injury trigger psoriatic arthritis? A review of the literature. Clin Rheumatol 2014, 33(5):601-608.
131. Olivieri I., Padula A., D'Angelo S., et al. Role of trauma in psoriatic arthritis. J Rheumatol 2008, 35(11):2085-2087.
132. Ozden M.G., Tekin N.S., Gürer M.A., et al. Environmental risk factors in pediatric psoriasis: a multicenter case-control study. Pediatr Dermatol 2011, 28(3):306-312.
133. Li W., Han J., Qureshi A. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012, 71(6):804-808.
134. Huerta C., Rivero E., Rodríguez L.A. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007, 143(12):1559-1565.
135. Eder L., Shanmugarajah S., Thavaneswaran A., et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis 2012, 71(2):219-224.
136. Pattison E., Harrison B., Griffiths C., et al. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008, 67(5):672-676.
137. Eder L., Law T., Chandran V., et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 2011, 63(8):1091-1097.
138. Tey H., Ee H., Tan A., et al. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol 2010, 37(5):426-430.
139. Ciurtin C., Roussou E. Cross-sectional study assessing family members of psoriatic arthritis patients affected by the same disease: differences between Caucasian, South Asian and Afro-Caribbean populations living in the same geographic region. Int J Rheum Dis 2013, 16(4):418-424.
140. Li W., Han J., Qureshi A. Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012, 71(8):1267-1772.
141. Love T., Zhu Y., Zhang Y., et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012, 71(8):1273-1277.
142. Soltani-Arabshahi R., Wong B., Feng B., et al. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010, 146(7):721-726.
143. Thumboo J., Uramoto K., Shbeeb M., et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 2002, 29(4):757-762.
144. Wu S., Li W.Q., Han J., et al. Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women. Arthritis Rheumatol 2014, 66(2):304-310.
145. Taylor S.L., Petrie M., O'Rourke K.S., et al. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms. J Dermatolog Treat 2009, 20(6):350-353.
146. Dominguez P., Gladman D.D., Helliwell P., et al. Development of screening tools to identify psoriatic arthritis. Curr Rheumatol Rep 2010, 12(4):295-299.
147. Haddad A., Chandran V. How can psoriatic arthritis be diagnosed early?. Curr Rheumatol Rep 2012, 14(4):358-363.
148. Fletcher R.H., Fletcher S.W. Clinical epidemiology: the essentials 2005, Lippincott Williams & Wilkins, Philadelphia. 4th edition.
149. Coates L., Aslam T., Al Balushi F., et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol 2013, 168(4):802-807.
150. Walsh J., Callis Duffin K., Krueger G., et al. Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. J Rheumatol 2013, 40(3):287-293.
151. Mease P., Gladman D., Helliwell P., et al. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2014, 71(4):649-655.
152. Husni M., Meyer K., Cohen D., et al. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007, 57(4):581-587.
153. Dominguez P., Husni M., Holt E., et al. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009, 301(8):573-579.
154. Ferreyra Garrott L., Soriano E., Rosa J., et al. Validation in Spanish of a screening questionnaire for the detection of psoriatic arthritis in patients with psoriasis. Rheumatology (Oxford) 2013, 52(3):510-514.
155. Husni M., Qureshi A., Koenig A., et al. Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: results from the PRISTINE trial. J Dermatolog Treat 2014, 25(1):90-95.
156. Merola J., Husni M., Qureshi A. Screening instruments for psoriatic arthritis. J Rheumatol 2013, 40(9):1623.
157. Gladman D., Schentag C., Tom B., et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009, 68(4):497-501.
158. Ibrahim G., Buch M., Lawson C., et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009, 27(3):469-474.
159. Khraishi M., Mong J., Mugford G., et al. The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients. J Cutan Med Surg 2011, 15(3):143-149.
160. Tinazzi I., Adami S., Zanolin E., et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford) 2012, 51(11):2058-2063.
161. Garg N., Truong B., Ku J., et al. A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic. Clin Rheumatol 2014, [Epub ahead of print].
162. Coates L., Walsh J., Haroon M., et al. Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken) 2014, 66(9):1410-1416.
163. Ogdie A., Schwartzman S., Husni M. Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 2015, 27(2):118-126.
164. Husted J., Thavaneswaran A., Chandran V., et al. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol 2013, 40(8):1349-1356.
165. Jamnitski A., Symmons D., Peters M.J.L., et al. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013, 72(2):211-216.
166. Gross R., Schwartzman-Morris J., Krathen M., et al. The risk of malignancy in a large cohort of patients with psoriatic arthritis. Arthritis Rheumatol 2014, 66(6):1472-1481.
167. Hellgren K., Smedby K., Backlin E., et al. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol 2014, 66(5):1282-1290.
168. Rohekar S., Tom B., Hassa A., et al. Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum 2008, 58(1):82-87.
169. Pedreira P., Pinheiro M., Szejnfeld V. Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis. Arthritis Res Ther 2011, 13(1):R16.
170. Grazio S., Cvijetić S., Vlak T., et al. Osteoporosis in psoriatic arthritis: is there any?. Wien Klin Wochenschr 2011, 123(23-24):743-750.
171. Del Puente A., Esposito A., Parisi A., et al. Osteoporosis and psoriatic arthritis. J Rheumatol Suppl 2012, 89:36-38.
172. Haddad A., Thavaneswaran A., Toloza S., et al. Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. J Rheumatol 2013, 40(8):1367-1773.
173. Eder L., Thavaneswaran A., Pereira D., et al. Prevalence of monoclonal gammopathy among patients with psoriatic arthritis. J Rheumatol 2012, 39(3):564-567.
174. Niccoli L., Nannini C., Cassarà E., et al. Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 2012, 15(4):414-418.
175. Ogdie A., Haynes K., Troxel A., et al. Mortality in patients with psoriatic arthritis compared to patients with rheumatoid arthritis, psoriasis alone, and the general population. Ann Rheum Dis 2014, 73(1):149-153.
176. Arumugam R., McHugh N. Mortality and causes of death in psoriatic arthritis. J Rheumatol Suppl 2012, 89:32-35.
177. Buckley C., Cavill C., Taylor G., et al. Mortality in psoriatic arthritis-a single-center study from the UK. J Rheumatol 2010, 37(10):2141-2144.
178. Wong K., Gladman D.D., Husted J., et al. Mortality studies in psoriatic arthritis: results from a single outpatient clinic; causes and risk of death. Arthritis Rheum 1997, 40(10):1868-1872.
179. Ali Y., Tom B.D.M., Schentag C.T., et al. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007, 56(8):2708-2714.
180. Han C., Robinson D.W., Hackett M.V., et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33:2167-2172.
181. Gladman D.D., Ang M., Su L., et al. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009, 68:1131-1135.
182. Tam L., Tomlinson B., Chu T., et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology (Oxford) 2008, 47:718-723.
183. Dubreuil M., Hee Rho Y., Man D., et al. The independent impact of psoriatic arthritis and rheumatoid arthritis on diabetes incidence: a UK population-based cohort study. Rheumatology (Oxford) 2014, 53(2):346-352.
184. Solomon D., Love T., Canning C., et al. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010, 69(12):2114-2117.
185. Haroon M., Gallagher P., Heffernan E., et al. High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 2014, 41(7):1357-1365.
186. Labitigan M., Bahče-Altuntas A., Kremer J., et al. Higher rates and clustering of abnormal lipids, obesity and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014, 66(4):600-607.
187. Pehlevan S., Yetkin D., Bahadir C., et al. Increased prevalence of metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord 2014, 12(1):43-48.
188. Li W., Han J., Manson J., et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol 2012, 166(4):811-818.
189. Ahlehoff O., Gislason G., Charlot M., et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011, 270(2):147-157.
190. Chin Y., Yu H., Li W., et al. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study. J Eur Acad Dermatol Venereol 2013, 27(10):1262-1268.
191. Bandinelli F., Prignano F., Bonciani D., et al. Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). Clin Exp Rheumatol 2013, 31(2):318-319.
192. Makredes M., Robinson D.J., Bala M., et al. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol 2009, 61(3):405-410.
193. Li W., Han J., Chan A., et al. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis 2013, 72(7):1200-1205.
194. Lima F., Abalem M., Ruiz D., et al. Prevalence of eye disease in Brazilian patients with psoriatic arthritis. Clinics (Sao Paulo) 2012, 67(3):249-253.
195. Antonelli A., Delle Sedie A., Fallahi P., et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol 2006, 33(10):2026-2028.